---
title: Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
date: '2023-11-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37966285
source: Trending page - PubMed
description: <span class="authors-list-item "><a class="full-name" href="https://pubmed.ncbi.nlm.nih.gov/?term=Bateman+RJ&amp;cauthor_id=37966285"
  ref="linksrc=author_name_link" data-ga-category="search" data-ga-action="author_link"
  data-ga-label="Randall J Bateman">Randall J Bateman</a><sup class="affiliation-links"><span
  class="author-sup-separator">&nbsp;</span><a class="affiliation-link" title="From
  the Department of Neurology, Washington University School of Medicine, St. Louis
  (R.J.B.); Roche Products, Welwyn Garden City (J.S., C.L.), and the Department of
  Brain Sciences, Faculty of Medicine, ...
disable_comments: true
---
<span class="authors-list-item "><a class="full-name" href="https://pubmed.ncbi.nlm.nih.gov/?term=Bateman+RJ&amp;cauthor_id=37966285" ref="linksrc=author_name_link" data-ga-category="search" data-ga-action="author_link" data-ga-label="Randall J Bateman">Randall J Bateman</a><sup class="affiliation-links"><span class="author-sup-separator">&nbsp;</span><a class="affiliation-link" title="From the Department of Neurology, Washington University School of Medicine, St. Louis (R.J.B.); Roche Products, Welwyn Garden City (J.S., C.L.), and the Department of Brain Sciences, Faculty of Medicine, ...